CXCL9 and neoplasm: CXCL9 and CXCL10, chemokines highly expressed in M1-type TAMs, especially those associated with inflammation, promote T cell recruitment, boosting anti-tumor immune responses, and are often observed in patients who respond well to immune checkpoint inhibitors.